Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001306260 | SCV001495622 | uncertain significance | Early myoclonic encephalopathy | 2020-04-27 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals with JMJD1C-related disease. This variant is present in population databases (rs757837342, ExAC 0.03%). This sequence change replaces glutamine with leucine at codon 268 of the JMJD1C protein (p.Gln268Leu). The glutamine residue is weakly conserved and there is a moderate physicochemical difference between glutamine and leucine. |
Al Jalila Children’s Genomics Center, |
RCV002486195 | SCV002775044 | uncertain significance | not provided | 2022-12-17 | criteria provided, single submitter | clinical testing |